Atrimustine

DB21376ExperimentalSmall molecule

Atrimustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Atrimustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative. Atrimustine has a... Atrimustine has a monoisotopic molecular weight of 719.28 Da.

Formula / weight: C₄₁H₄₇Cl₂NO₆ · 720.73 g/mol (avg)

Resolves to

Compound

UNIIXC0K09B7K4CAS75219-46-4ChEMBLCHEMBL2106381ChEBI751978PubChem6917688

Structure

InChIKeyIFJUINDAXYAPTO-UUBSBJJBSA-NSMILES

[H][C@@]12CC[C@H](OC(=O)COC(=O)CCCC3=CC=C(C=C3)N(CCCl)CCCl)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OC(=O)C1=CC=CC=C1)C=C3

Which companies are running trials of Atrimustine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account